Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles

Human Gene Therapy

Volumn 10, Issue 8, 1999, Pages 1299-1310

  Gilbert, Rénald ^a   Nalbantoglu, Josephine ^a   Petrof, Basil J ^b   Ebihara, Satoru ^b   Guibinga, Ghiabe Henri ^b   Tinsley, Jonathon M ^c   Kamen, Amine ^d   Massie, Bernard ^d   Davies, Kay E ^c   Karpati, George ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DYSTROPHIN; EVANS BLUE; TRACER; UTROPHIN; VIRUS VECTOR;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GENE OVEREXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; MECHANICAL STRESS; MOUSE; MUSCLE STRENGTH; NEWBORN; NONHUMAN; PHENOTYPE; TIBIALIS ANTERIOR MUSCLE;

ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; CYTOSKELETAL PROTEINS; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, INBRED MDX; MUSCLES; MUSCULAR DYSTROPHIES; PHENOTYPE; UTROPHIN;

ADENOVIRIDAE; ANIMALIA;

EID: 0033587139     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430349950017987     Document Type: Article

References (46)

1. ACSADI, G., LOCHMÜLLER, H., JANI, A., HUARD, J., MASSIE, B., PRESCOTT, S., SIMONEAU, M., PETROF, B.J., and KARPATI, G. (1996). Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum. Gene Ther. 7, 129-140.
2. BLAKE, D.J., TINSLEY, J.M., and DAVIES, K.E. (1996). Utrophin: A structural and functional comparison to dystrophin. Brain Pathol. 6, 37-47.
3. BRENMAN, J.E., CHAO, D.S., XIA, H., ALDAPE, K., and BREDT, D.S. (1995). Nitric oxide synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82, 743-752.
4. DAI, Y., SCHWARZ, E.M., GU, D., ZHANG, W.W., SARVETNICK, N., and VERMA, I.M. (1995). Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. U.S.A. 92, 1401-1405.
5. DECONINCK, N., RAGOT, T., MARÉCHAL, G., PERRICAUDET, M., and GILLIS, J.M. (1996). Functional protection of dystrophic mouse (mdx) muscles after adenovirus-mediated transfer of a dystrophin minigene. Proc. Natl. Acad. Sci. U.S.A. 93, 3570-3574.
6. DECONINCK, N., TINSLEY, J., DE BACKER, F., FISHER, R., KAHN, D., PHELPS, S., DAVIES, K.E., and GILLIS, J.-M. (1997). Expression of truncated utrophin leads to major functional improvements in dystrophin-deficient muscles of mice. Nature Med. 3, 1216-1221.
7. cv diaphragm muscle fibers increases sarcolemmal stability. Gene Ther. 4, 401-408.
8. ENGEL, A.G., YAMAMOTO, M., and FISCHBECK, K.H. (1994). Dystrophinopathies. In Myology, 2nd ed. A.G. Engel and C. Franzini-Armstrong, eds. (McGraw-Hill, New York) pp. 1133-1187.
9. GILBERT, R., NALBANTOGLU, J., TINSLEY, J.M., MASSIE, B., DAVIES, K.E., and KARPATI, G. (1998). Efficient utrophin expression following adenovirus gene transfer in dystrophic muscle. Biochem. Biophys. Res. Commun. 242, 244-247.
10. GRAHAM, F.L., and PREVEC, L. (1991). Manipulation of adenovirus vector. In Gene Transfer and Expression Protocols. E.J. Murray, ed. (Humana Press, Clifton, NJ) pp. 109-114.
11. GUIBINGA, G.-H., LOCHMÜLLER, H., MASSIE, B., NALBANTOGLU, J., KARPATI, G., and PETROF, B.J. (1998). Combinatorial blockade of calcineurin and CD28 signaling facilitates primary and secondary therapeutic gene transfer by adenovirus vectors in dystrophic (mdx) mouse muscles. J. Virol. 72, 4601-4609.
12. HARRINGTON, W.F., and RODGERS, M.E. (1984). Myosin. Annu. Rev. Biochem. 53, 35-73.
13. HOWELL, J.M., LOCHMÜLLER, H., O'HARA, A., FLETCHER, S., KAKULAS, B.A., MASSIE, B., NALBANTOGLU, J., and KARPATI, G. (1998). High-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic [GRMD] dogs: Prolongation of expression with immunosuppression. Hum. Gene Ther. 9, 629-634.
14. JANI, A., LOCHMÜLLER, H., ACSADI, G., SIMONEAU, M., HUARD, J., GARNIER, A., KARPATI, G., and MASSIE, B. (1997). Generation, validation, and large scale production of adenoviral recombinants with large size inserts such as a 6.3 kb human dystrophin cDNA. J. Virol. Methods 64, 111-124.
15. JOOSS, K., ERTL, H.C.J., and WILSON, J.M. (1998a). Cytotoxic T-lymphocyte target proteins and their major histocompatibility complex class I restriction in response to adenovirus vectors delivered to mouse liver. J. Virol. 72, 2945-2954.
16. JOOSS, K., YANG, Y., FISHER, K.J., and WILSON, J.M. (1998b). Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers. J. Virol. 72, 4212-4223.
17. KARPATI, G., CARPENTER, S., and PRESCOTT, S. (1988). Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy. Muscle Nerve 11, 795-803.
18. KARPATI, G., CARPENTER, S., MORRIS, G.E., DAVIES, K.E., GUERIN, C., and HOLLAND, P. (1993). Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol. 52, 119-128.
19. KOCHANEK, S., CLEMENS, P.R., MITANI, K., CHEN, H.-H., CHAN, S., and CASKEY, T. (1996). A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and β-galactosidase. Proc. Natl. Acad. Sci. U.S.A. 93, 5731-5736.
20. LOCHMÜLLER, H., JANI, A., HUARD, J., PRESCOTT, S., SIMONEAU, M., MASSIE, B., KARPATI, G., and ACSADI, G. (1994). Emergence of early region 1-containing replication-competent adenovirus in stocks of replication-defective adenovirus recombinants (ΔE1 + ΔE3) during multiple passages in 293 cells. Hum. Gene Ther. 5, 1485-1491.
21. LOCHMÜLLER, H., PETROF, B.J., ALLEN, C., PRESCOTT, S., MASSIE, B., and KARPATI, G. (1995). Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. Biochem. Biophys. Res. Commun. 213, 569-574.
22. LOCHMÜLLER, H., PETROF, B.J., PARI, G., LAROCHELLE, N., DODELET, V., WANG, Q., ALLEN, C., PRESCOTT, S., MASSIE, B., NALBANTOGLU, J., and KARPATI, G. (1996). Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice. Gene Ther. 3, 706-716.
23. MICHOU, A.I., SANTORO, L., CHRIST, M., JULLIARD, V., PAVIRANI, A., and MEHTALI, M. (1997). Adenovirus-mediated gene transfer: Influence of transgene, mouse strain and type of immune response on persistence of transgene expression. Gene Ther. 4, 473-482.
24. NGUYEN THI MAN, M., ELLIS, J.M., LOVE, D.R., DAVIES, K.E., GATTER, K.C., DICKSON, G., and MORRIS, G.E. (1991). Localization of the DMDL gene-encoded dystrophin-related protein using a panel of nineteen monoclonal antibodies: presence at neuromuscular junctions, in the sarcolemma of dystrophic skeletal muscle, in vascular and other smooth muscles, and proliferating brain cell lines. J. Cell Biol. 115, 1695-1700.
25. OHLENDIECK, K., and CAMPBELL, K.P. (1991). Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J. Cell Biol. 115, 1685-1694.
26. OHLENDIECK, K., MATSUMURA, K., IONASESCU, V.V., TOWBIN, J.A., BOSH, E.P., WEINSTEIN, S.L., SERNETT, B.S., and CAMPBELL, K.P. (1993). Duchenne muscular dystrophy: Deficiency of dystrophin-associated proteins in the sarcolemma. Neurology 43, 795-800.
27. OHTSUKA Y., UDAKA, K., YAMASHIRO, Y., YAGITA, H., and OKUMURA, K. (1998). Dystrophin acts as a transplantation rejection antigen in dystrophin-deficient mice: Implication for gene therapy. J. Immunol. 160, 4635-4640.
28. PETROF, B.J., SHRAGER, J.B., STEDMAN, H.H., KELLY, A.M., and SWEENEY, H.L. (1993). Dystrophin protects the sarcolemma from the stresses developed during muscle contraction. Proc. Natl. Acad. Sci. U.S.A. 90, 3710-3714.
29. RAFAËL, J.A., TINSLEY, J.M., POTTER, A.C., DECONINCK, A.E., and DAVIES, K.E. (1998). Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nature Genet. 19, 79-82.
30. RAGOT, T., VINCENT, N., CHAFEY, P., VIGNE, E., GILGENKRANTZ, H., COUTON, D., CARTAUD, J., BIRAND, P., KAPLAN, J.-C., PERRICAUDET, M., and KAHN, A. (1993). Efficient adenovirus-mediated transfer of a human minidystrophin gene to skeletal muscle of mdx mice. Nature (London) 361, 647-650.
31. SADOULET-PUCCIO, H.M., and KUNKEL, L.M. (1996). Dystrophin and its isoforms. Brain Pathol. 6, 25-35.
32. STARR, R., and OFFER, G. (1982). Preparation of C-protein, H-protein, X-protein, and phosphofructokinase. Method Enzymol. 85, 130-138.
33. STRAUB, V., and CAMPBELL, K.P. (1997). Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10, 168-175.
34. STRAUB, V., RAFAEL, J.A., CHAMBERLAIN, J.S., and CAMPBELL, K.P. (1997). Animal models for muscular dystrophy show different patterns of sarcolemmal disruption. J. Cell Biol. 139, 375-385.
35. TINSLEY, J.M., BLAKE, D.J., ROCHE, A., FAIRBROTHER, U., RISS, J., BYTH, B.C., KNIGHT, A.E., KENDRICK-JONES, J., SUTHERS, G.K., LOVE, D.R., EDWARDS, Y.H., and DAVIES, K.E. (1992). Primary structure of dystrophin-related protein. Nature (London) 360, 591-592.
36. TINSLEY, J.M., POTTER, A.C., PHELPS, S.R., FISHER, R., TRICKETT, J.I., and DAVIS, K.E. (1996). Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature (London) 384, 349-353.
37. TINSLEY, J., DECONINCK, N., FISHER, R., KAHN, D., PHELPS, S., GILLIS, J.-M., and DAVIES, K. (1998). Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nature Med. 4, 1441-1444.
38. TRIPATHY, S.K., BLACK, H.B., GOLDWASSER, E., and LEIDEN, M.J. (1996). Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nature Med. 2, 545-550.
39. VINCENT, N., RAGOT, T., GILGENKRANTZ, H., COUTON, D., CHAFEY, P., GREGOIRE, A., BRIAND, P., KAPLAN, J.-C., KAHN, A., and PERRICAUDET, M. (1993). Long-term correction of mouse dystrophic degeneration by adenovirus-mediated transfer of a minidystrophin gene. Nature Genet. 5, 130-134.
40. WATKINS, S.C., HOFFMAN, E.P., SLAYTER, H.S., and KUNKEL, L.M. (1988). Immunoelectron microscopic localization of dystrophin in myofibres. Nature (London) 333, 863-866.
41. WELLER, B., KARPATI, G., and CARPENTER, S. (1990). Dystrophin-deficient mdx muscle fibers are preferentially vulnerable to necrosis induced by experimental lengthening contractions. J. Neurol. Sci. 100, 9-13.
42. WINDER, S.J., GIBSON, T.J., and KENDRICK-JONES, J. (1995). Dystrophin and utrophin: The missing links! FEBS Lett. 369, 27-33.
43. YANG, L., LOCHMÜLLER, H., LUO, J., MASSIE, B., NALBANTOGLU, J., KARPATI, G., and PETROF, B.J. (1998). Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (mdx) mice. Gene Ther. 5, 369-379.
44. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GÖNCZÖL, E., and WILSON, J.M. (1994). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. U.S.A. 91, 4407-4411.
45. YANG, Y., HAECKER, S.E., SU, Q., and WILSON, J.M. (1996). Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. Hum. Mol. Genet. 5, 1703-1712.
46. ZUBRZYCKA-GAARN, E.E., BULMAN, D.E., KARPATI, G., BURGHES, A.H.M., BELFALL, B., KLAMUT, H.J., TALBOT, J., HODGES, R.S., RAY, P.N., and WORTON, R.G. (1988). The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature (London) 322, 466-469.